| | 56518-41-3 Basic information More.. |
| Product Name: | Brodimoprim | | Synonyms: | 5-(3,5-dimethoxy-4-bromobenzyl)-2,4-diaminopyrimidine;brodimoprim;5-((4-bromo-3,5-dimethoxyphenyl)methyl)-2,4-pyrimidinediamine;5-((4-bromo-3,5-dimethoxyphenyl)methyl)-4-pyrimidinediamine;bromdimoprim;5-(3,5-Dimethoxy-4-bromobenzyl)-2,4-pyrimidinediamine;5-(4-Bromo-3,5-dimethoxybenzyl)pyrimidine-2,4-diamine;Bromidoprim | | CAS: | 56518-41-3 | | MF: | C13H15BrN4O2 | | MW: | 339.1878 | | EINECS: | 2602388 | | Mol File: | 56518-41-3.mol |  |
Use
Brodimoprim, a dihydrofolate reductase inhibitor, was introduced for the treatment of
common infections of upper respiratory tract such as sinusitis and exacerbation of chronic
bronchitis. It has a broad spectrum of antimicrobial activities against most Gram-positive and
-negative pathogens including some bacterial strains that are resistant to amoxicillin, a widely
used antibiotic for the indicated infections. Brodimoprim also has a favorable pharmacokinetic
profile exemplified by its long half-life and good tissue penetration.
- Brodimoprim USP/EP/BP
-
- US $1.10 / g
- 2021-07-17
- CAS:56518-41-3
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
- Brodimoprim
-
- US $0.01-1.00 / KG
- 2020-05-13
- CAS:56518-41-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50 tons
|
|
56518-41-3
Recommend Suppliers |
|